Delivery Order SPE2DB22D3004-SPE2DB24FPZ55
- Not listed
- This federal contract award, valued at $5,169.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a critical medication, to support military treatment facilities and other federal healthcare providers. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,027.94 Firm Fixed Price Delivery Order (SPE2DX15D1022|SPE2DX23FVGVL) is for the supply of Phenobarbital 130 mg/ml vials. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as...
- This federal contract award, valued at $2,457.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PHENOBARBITAL 65 MG/ML VIALML. The award has an ultimate completion date of November 6, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide PHENOBARBITAL 65 MG/ML VIALML, a pharmaceutical product, with a potential value of $1,334.21. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not a set-aside contract. This delivery order is issued under an Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.43, is for the delivery of PHENOBARBITAL 130 MG/ML VIALML to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award, valued at $5,892.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of January 7, 2025, is for the delivery of Phenobarbital 130 mg/ml vials. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is for the delivery of PHENOBARBITAL 65 MG/ML VIALML to the U.S. Department of Defense (DoD) and its agencies. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $1,223.55. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award...
- The Defense Logistics Agency awarded a $3,837.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Phenobarbital 65 mg/ml vial on December 31, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567265456 - PHENOBARBITAL 130 MG/ML VIALML. The contract has a ceiling value of $3,147.26 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of February 14, 2025. This award does not have a set-aside designation, indicating it was open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $1,640.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Phenobarbital 65 mg/ml vials. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which specializes in providing a wide range of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPZ55Delivery Order
This federal contract award, valued at $2,117.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Phenobarbital 130 mg/ml vials and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/15/24 |